Pubblicazioni

Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARÎ±) in Non-Somatotroph Pituitary Tumours and the Effects of PPARÎ± Agonists on MMQ Cells

2018 - HORMONE AND METABOLIC RESEARCH

Polidoro, Michela Anna; Rotondi, Sandra; Morace, Roberta; Rostomyan, Liliya; Colapietro, Alessandro; Arcella, Antonietta; Ventura, Luca; Angelucci, Adriano; Giangaspero, Felice; Esposito, Vincenzo; Beckers, Albert; Jaffrain-Rea, Marie-Lise

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells

2016 - MOLECULAR AND CELLULAR ENDOCRINOLOGY

Rotondi, Sandra; Modarelli, Alessio; Oliva, Maria-Antonietta; Rostomyan, Liliya; Sanita, Patrizia; Ventura, Luca; Daly, Adrian F.; Esposito, Vincenzo; Angelucci, Adriano; Arcella, Antonietta; Giangaspero, Felice; Beckers, Albert; Jaffrain-Rea, Marie-Lise

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

2016 - EUROPEAN HEART JOURNAL SUPPLEMENTS

Ferrari, R; Aguiar, C; Alegria, E; Bonadonna, Rc; Cosentino, F; Elisaf, M; Farnier, M; FerriÃ¨res, J; Filardi, Pp; Hancu, N; Kayikcioglu, M; Mello, E Silva A; Millan, J; Reiner, Å½; Tokgozoglu, L; Valensi, P; Viigimaa, M; Vrablik, M; Zambon, A; Zamorano, Jl; Catapano, Al

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia. A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy

2015 - ATHEROSCLEROSIS SUPPLEMENTS

Aguiar, Carlos; Alegria, Eduardo; Bonadonna, Riccardo C.; Catapano, Alberico L.; Cosentino, Francesco; Elisaf, Moses; Farnier, Michel; FerriÃ¨res, Jean; Filardi, Pasquale Perrone; Hancu, Nicolae; Kayikcioglu, Meral; Mello e. Silva, Alberto; Millan, Jesus; Reiner, Å½eljko; Tokgozoglu, Lale; Valensi, Paul; Viigimaa, Margus; Vrablik, Michal; Zambon, Alberto; Zamorano, JosÃ© Luis; Ferrari, Roberto

Pubblicazioni

Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARÎ±) in Non-Somatotroph Pituitary Tumours and the Effects of PPARÎ± Agonists on MMQ Cells

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia. A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells